Immunotech Biopharm Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-230.79	-186.91	-334.82	-318.11	-354.22
Depreciation & Amortization	53.46	59.3	52.22	43.11	20.82
Other Amortization	1.84	1.58	1.18	14.46	0.19
Loss (Gain) From Sale of Assets	0.03	0.04	-0.2	0.64	0.09
Asset Writedown & Restructuring Costs	-	0.56	-	-	-1.3
Loss (Gain) From Sale of Investments	-0.19	19.81	90.01	24.02	18.79
Stock-Based Compensation	-	-	-	4.29	48.95
Other Operating Activities	65.18	-42.27	15.67	5.59	-7.04
Change in Inventory	1.03	-0.62	2.29	3.65	-6.89
Change in Accounts Payable	7.5	-17.27	4.09	8.41	38.87
Change in Unearned Revenue	-1.05	0.56	-0.71	3.29	-0.35
Change in Other Net Operating Assets	5.7	39.48	6.63	29.74	-12.56
Operating Cash Flow	-97.29	-125.74	-163.63	-180.92	-254.65
Capital Expenditures	-14.06	-27.26	-19.58	-68.15	-146.01
Sale of Property, Plant & Equipment	0.02	0.03	0.96	1.5	0.21
Sale (Purchase) of Intangibles	-0.57	-0.81	-2.96	-7.55	-22.32
Sale (Purchase) of Real Estate	-	-	-	-20.87	-12.91
Investment in Securities	-89.38	140.83	-100	78.06	-150.09
Other Investing Activities	5.93	28.31	4.99	40.39	2.91
Investing Cash Flow	-98.07	141.1	-116.6	23.38	-328.21
Short-Term Debt Issued	44.91	-	-	-	-
Long-Term Debt Issued	-	-	300	1	-
Total Debt Issued	44.91	-	300	1	-
Short-Term Debt Repaid	-44.91	-	-	-	-
Long-Term Debt Repaid	-20.36	-13.1	-17.56	-17.43	-7.32
Total Debt Repaid	-65.27	-13.1	-17.56	-17.43	-7.32
Net Debt Issued (Repaid)	-20.36	-13.1	282.44	-16.43	-7.32
Issuance of Common Stock	234.64	-	-	-	-
Other Financing Activities	-11.09	-7.49	-8.52	-19.63	-3.68
Financing Cash Flow	203.2	-20.59	273.92	-36.06	-11
Foreign Exchange Rate Adjustments	-0.34	0.02	0.02	0.65	-0.13
Net Cash Flow	7.5	-5.2	-6.29	-192.95	-593.99
Free Cash Flow	-111.35	-153	-183.21	-249.07	-400.67
Free Cash Flow Per Share	-0.20	-0.28	-0.36	-0.48	-0.78
Cash Interest Paid	6.6	7.49	8.52	6.14	3.68
Cash Income Tax Paid	0.96	-0.04	-	-	-
Levered Free Cash Flow	-66.3	-134.61	-120.8	-146.34	-201.44
Unlevered Free Cash Flow	-62.05	-129.93	-115.47	-156	-199.15
Change in Working Capital	13.18	22.16	12.31	45.09	19.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.